Is It Essential Tremor or a Parkinsonian Syndrome? Diagnostic Considerations in Primary Care Faculty Tanya Simuni, MD Director, Parkinson's Disease and.

Slides:



Advertisements
Similar presentations
MOTOR NEURON DISEASE The motor neuron diseases (or motor neuron diseases) (MND) are a group of neurological disorders that selectively affect motor neurons.
Advertisements

APOE Genotype Effects on Alzheimer’s Disease Clinical Onset, Epidemiology, and Gompertzian Aging Functions J.Wesson Ashford, M.D., Ph.D. Stanford / VA.
Evaluation of Movement Disorders
Leslie Cloud, MD Department of Neurology Division of Movement Disorders Emory University School of Medicine.
Parkinson’s Disease (PD)
Frontotemporal Dementia
The PARticulars of Parkinson’s Disease
Parkinson’s Disease Dr Rachel Cary, Warwick Hospital.
MDS-PAS School for Young Neurologists Video Dinner February 21, 2015 Maria Eliza T. Freitas, MD Clinical Fellow In Movement Disorder University of Toronto.
Halim Fadil, MD: Movement Disorder Neurologist Susan Imke, FNP: Gerontological Nurse Practitioner In partenership with: Abdolreza Siadati, MD, Neurosurgeon.
PHL 437/Pharmacogenomics Fourth Lecture (Parkinson’s disease) By Abdelkader Ashour, Ph.D. Phone:
Paul Short, Ph.D. The Parkinson’s Coach NEUROPSYCHOLOGY OF PARKINSON’S COMMUNICATION PROBLEMS.
Parkinson’s Disease Dementia (PDD) A Clinical Perspective
Erica Partridge Parkinson’s Disease. Definition Aetiology PD vs Parkinsonism Symptoms and signs Differentials Investigations Management Prognosis.
931-4 Convergence Insufficiency. History A 73-year old man with known PD for 10 years, complained of horizontal double vision for 18 months. He could.
Parkinson ’ s disease. Function Anatomy of Parkinson ’ s Disease.
Alzheimer’s Assessment Assessing the Cognitive-Linguistic effects of Alzheimer’s.
JP Parkinson’s Disease. Overview Idiopathic PD Clinically and pathologically distinct from other parkinsonian syndromes Degenerative disorder of the CNS.
Parkinson’s Disease By Devin Cornford
Neurodegeneration is the umbrella term for the progressive loss of structure or function of neurons, including death of neurons. Many neurodegenerative.
Neurological Manifestations of Wilson’s Disease Aleksandar Videnovic, MD, MSc Assistant Professor of Neurology Feinberg School of Medicine Northwestern.
Initial presentation of multiple sclerosis in northern Iran; Is there any comparison to other countries Initial presentation of multiple sclerosis in northern.
Duodenal Levodopa Treatment in advanced Parkinson’s Disease
Parkinson’s Disease. Definition Parkinson's disease (PD) is an idiopathic, slowly progressive, neurodegenerative disorder whereby two or more of the following.
Parkinson’s Plus By: Glen Estrosos.
Parkinson’s Disease superKAT :).
Alzheimer’s Disease The most common cause of Dementia –Progressive Memory Loss Plus loss in one other area of cognition: Perception Attention Language/Symbols.
Surgery for Parkinson’s Disease: Focus on Deep Brain Stimulation Ramón L Rodríguez, MD Director of Clinical Services University of Florida Movement Disorders.
PARKINSON’S DISEASE By Courtney and Niral. WHAT IS IT?  Parkinson's disease (PD) is chronic and progressive movement disorder, meaning that symptoms.
Innovations in Parkinson’s Diagnosis & Treatment: A Personal Story Dr. Kenneth E. Keirstead Excellence in Aging Care Symposium September 25-27, 2013.
Jack Twersky, MD Medical Director CLC Durham.  Memory impairment and at least one of the following  Aphasia  Apraxia  Agnosia  Executive function.
Teaching NeuroImages An 83-year-old woman with phonatory breaks and left hand rest tremor Neurology Resident and Fellow Section © 2013 American Academy.
Treatment of Parkinson Disease David Tran, 2013 Mercer University PharmD Candidate.
Mostly Parkinson’s disease but also few other movement disorders due to diseases of the basal ganglia.
Analyzing the Potential of a Diagnostic Tool for PD Ben Oren, Ezra Brettler, Uri Ron, and Ying Wang MKTG
Richard Leckey Oct 2,2015.  Faculty: Dr. Richard Leckey  Relationships with commercial interests:  Biogen  Merck  Serono  Novartis  Allergen CFPC.
“3 D’s” of Geriatrics Dementia, Delirium, and Depression These common disorders can look alike. GAI often helps uncover or differentiate them. All are.
PARKINSON’S DISEASE By: AARUSHI JAIN AMRUTA KAMBLE ANNETT MARY JACOB AVANTI DEO M.Sc. PRIST (09-11)
 Parkinson’s Disease (PD) -progressive neurodegenerative disease affecting motor ability -third most common neurologic disorder of older adults.
second most common neurodegenerative disorder progressive loss of muscle control trembling of the limbs and head while at rest stiffness, slowness, and.
By Rahul Kapoor. Based on a study performed by Stephen McGowan MRCPsych Andrew D. LawrenceMRCPsych Tim Sales MRCPsych Digby Quested MRCPsych Paul Grasby.
Parkinson’s Disease Angela Duncan June Why I Chose This Subject Common neurodegenerative disorder / in Scotland Expected increase.
Pathogenesis and pathology of parkinsonism
Structural and Functional Neuroimaging in the Diagnosis of Dementia John M. Ringman, M.D. Assistant Professor UCLA Department of Neurology.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Pharmacological Treatment of Parkinson Disease: A.
© 2006 American Academy of Neurology Practice Parameter: Diagnosis and Prognosis of New Onset Parkinson Disease (An Evidence-Based Review) American Academy.
Reflections on animal models of neurological disorders Marie-Francoise Chesselet UCLA
Frontotemporal Lobar Degeneration:
“HEALTH IS THE BEST” In the name of God. WHAT IS IT? Parkinson's disease (PD) is a chronic and progressive movement disorder, meaning that symptoms.
Parkinson’s Disease.
59 year old man w visual hallucinations
Dementia with Lewy Bodies
Summary & Conclusion Introduction Methods Background RESULTS Methods
Parkinson’s Disease Celsey and Chylee.
Unit 40 Dementia care.
Parkinson's disease KRZYSZTOF NICPOŃ.
Treatment of Parkinson’s disease
“The effects of chronic changes to the functioning of the nervous system due to interference to neurotransmitter function, illustrated by the role of Dopamine.
Parkinson’s disease.
Parkinson's disease Parkinson's disease (PD) is the second-most common
Long Term Effects of Concussions
The Approach to Tremor (with case examples) Praveen Dayalu MD Associate Professor Department of Neurology University of Michigan.
Atypical Parkinsonian Syndromes
Phenoconversion in PPMI
Mark S. Forman, Virginia M-Y. Lee, John Q. Trojanowski  Neuron 
Neurodegenerative diseases
Essential Tremor: Red Flags/Epidemiology
The Memory Assessment and Treatment Service (MATS)
supported study by Dr. Heiko Gaßner and Dr. Cecilia Raccagni
Presentation transcript:

Is It Essential Tremor or a Parkinsonian Syndrome? Diagnostic Considerations in Primary Care Faculty Tanya Simuni, MD Director, Parkinson's Disease and Movement Disorders Center Northwestern University Chicago, Illinois

Outline challenges to accurate and timely diagnosis of Parkinson disease (PD) in the primary care setting Compare clinical signs and symptoms of PD and other parkinsonian syndromes with those of essential tremor Recognize when neuroimaging is appropriate in the diagnostic workup of patients with suspected parkinsonian syndromes Learning Objectives

Epidemiology of PD in the United States 1 million patients have PD Annual incidence:15-20 per 100,000 −50,000-60,000 new cases per year Prevalence increases with age (per 100,000) −40-49 years: 23 −70-79 years: 525 −80-89 years: 1145 More common in whites vs blacks or Asians More common in Midwest and Northeast vs other regions; more common in urban vs rural counties Watts RL, et al [1] ; Willis AW, et al. [2]

UK PDSBB Clinical Diagnostic Criteria Step 1: Diagnosis Bradykinesia At least 1 −Muscular rigidity −4-6 Hz rest tremor −Postural instability Not visual Not vestibular Not cerebellar Not sensory Hughes AJ, et al. [3]

UK PDSBB Clinical Diagnostic Criteria Step 2: Exclusion Criteria History of repeated strokes, repeated head injury, or definite encephalitis Oculogyric crises Neuroleptic treatment at onset of symptoms Sustained remission Strictly unilateral after 3 years Supranuclear gaze palsy Cerebellar signs; early autonomic involvement Early, severe dementia; Babinski sign Cerebral tumor or hydrocephalus on CT MPTP exposure Poor response to levodopa Hughes AJ, et al. [3]

3 or more required for definite diagnosis Unilateral onset Rest tremor Progressive disorder Persistent asymmetry, worse on onset side 70%-100% response to levodopa Severe levodopa-induced dyskinesias Levodopa response ≥ 5 years Disease course ≥ 10 years UK PDSBB Clinical Diagnostic Criteria Step 3: Supportive Positive Criteria Hughes AJ, et al. [3]

UK PDSBB Clinical Diagnostic Criteria Diagnostic Accuracy Initial study a : 100 cases with PD diagnosed prospectively 76% accuracy on autopsy Criteria applied retrospectively improved accuracy to 82% Follow-up study b : Criteria applied prospectively in 100 cases 90% accuracy on autopsy a. Hughes AJ, et al [3] ; b. Hughes AJ, et al. [4]

Diagnostic Accuracy Improves With Disease Duration: Imaging Studies Proportion of SWEDDs decreases with length of time since diagnosis Clinical trials: −ELLDOPA: 14% SWEDDs at 6 months −REAL-PET: 12% SWEDDs at 9 months −CALM-PD: 4% SWEDDs at 18 months −NIL-A-CIT: 2% SWEDDs at 22 months SWEDD=scan without evidence of dopaminergic deficit; indicates misdiagnosis of parkinsonism. Seibyl J, et al. [5]

Other Neurodegenerative Disorders With Presynaptic Dopamine Deficiency More common Progressive supranuclear palsy Multiple system atrophy Corticobasal ganglionic degeneration Diffuse Lewy body disease Less common ALS-Parkinsonism-Dementia/of Guam Alzheimer with extrapyramidal signs Rigid variant of Huntington disease

Parkinsonian Syndromes Parkinsonian syndromes refer to neurologic disorders associated with a loss of dopamine neurons PD (~85% of cases of parkinsonism) a MSA (< 5%) a PSP (< 5%) a Does not include cases of clinical parkinsonism where there is not an associated loss of dopamine neurons Drug-induced parkinsonism (7%-35% of all cases of parkinsonism) a,b,c Vascular parkinsonism (~4%-12%) d Psychogenic parkinsonism (0.17%-0.5%) b a. Rajput AH, et al [6] ; b. Kägi G, et al [7] ; c. Thanvi B, Treadwell S [8] ; d. Thanvi B, et al. [9]

What Is ET? ET is a specific neurologic disorder Also known as “familial tremor” Tremor involves hands, head, voice, sometimes legs and trunk Essential means −There is no other cause for tremor −There are no other neurologic signs Familial means it can be hereditary

Other Causes of Tremor Medication induced Electrolyte imbalance Thyroid dysfunction PD Posttraumatic tremor MS-related tremor Other neurologic conditions

Manifestations of ET Symmetric tremor Tremor is the single manifestation (can include hand, vocal, head, trunk, leg tremors) Postural, kinetic (associated with action) tremor

How Common Is ET? ET is the most common movement disorder −About 5% of people age > 65 y have ET ET frequently is not diagnosed ET usually starts age ≥ 40 y but can be seen in childhood ET symptoms start insidiously and progress slowly ET is not dangerous but can be disabling Louis ED. [10]

Is ET Related to PD? NO, NO, NO ET tremor differs from PD ET patients do not feel slow or stiff ET patients do not have difficulty walking ET does not progress into PD Some patients can have both diagnoses

Areas of Uncertainty Definite PD a Areas of Clinical Uncertainty b-f Definite ET g Asymmetric tremorMixed tremor typesSymmetric tremor Resting tremorQuestionable bradykinesia Postural and kinetic (action) tremor Bradykinesia Questionable response to dopaminergic therapy Voice or head tremor Rigidity Family history of tremor Ambiguous/Overlapping Symptoms PD symptoms + postural and kinetic tremors ET symptoms + symmetric tremor + rest tremor + no bradykinesia+ cogwheeling present + no rigidity a. Lees AJ, et al [11] ; b. Hauser RA, et al [12] ; c. Pahwa R, et al [13] ; d. Hauser RA, et al [14] ; e. Solida A, et al [15] ; f. Marshall V, et al [16] ; g. Bhidayasiri R. [17]

Misdiagnosis of ET and PD Is Common Clinical studies have found a high level of misdiagnosis of ET and PD A previous diagnosis of PD was rejected in 15% of patients using standardized criteria and > 1 year follow-up a ~26% of patients receiving antiparkinsonian medication did not have a parkinsonian syndrome b A previous diagnosis of ET was rejected in 37% of patients using standardized criteria c a. Schrag A, et al [18] ; b. Meara J, et al [19] ; c. Jain S, et al. [20]

Woman age 60 y presents for evaluation of a long-standing tremor 7-year history of bilateral symmetric hand tremor that occurs with activity and is especially bothersome when she writes or holds a cup Tremor improves with wine. Her father had a similar tremor Not bothersome but has increased in past several months Recently noticed occasional right-arm tremor at rest Case Presentation

Case Presentation (cont) Neurologic examination Bilateral action tremor when she holds a cup Slight rest tremor component in the right arm Trace of increased tone in the right wrist Normal balance and gait No other medical history

SPECT and PET Ligands The most commonly used SPECT ligands bind to the striatal presynaptic membrane- associated dopamine active transporter protein Reduction of the dopamine transporter correlates with the loss of presynaptic dopamine Other ligands measure −Vesicular monoamine transport −DOPA decarboxylase activity

Dopamine System Imaging Presynaptic radioligands DOPA decarboxylase (measures dopamine synthesis) DAT (provides measure of functioning dopaminergic terminals) VMAT-2 (marker for dopaminergic terminals) Postsynaptic radioligands D 2 receptor Amino Acid Transporter Mitochondrion VMAT-2 Vesicle DAT Dopamine D 2 Receptor Cummings JL, et al. [21] Adapted with permission.

Patients with a classic presentation of PD or ET do not require additional diagnostic imaging Dopamine transporter SPECT cannot differentiate different forms of parkinsonism (eg, PD, MSA, PSP) Features that raise concerns about an alternative cause of parkinsonism that could prompt diagnostic imaging −Patients with atypical features that are beyond the scope of a classic PD presentation −Patients with poor response to an appropriate trial of dopaminergic therapy Who Benefits From Diagnostic Imaging?

Dopaminergic Imaging vs Normal DiagnosisFindings on Dopaminergic Imaging Parkinson disease Reduced striatal dopamine synthesis Reduced dopamine storage Reduced dopamine release Reduced dopamine transporter Dementia with Lewy bodies, PD with dementia, MSA, PSP, corticobasal degeneration Reduced striatal dopamine synthesis Reduced dopamine storage Reduced dopamine transporter Vascular parkinsonism Possible variable reductions in dopamine function ETNo alterations in dopamine function Drug-induced parkinsonismNo alterations in dopamine function Psychogenic parkinsonismNo alterations in dopamine function Alzheimer diseaseNo alterations in dopamine function Cummings JL, et al. [21] Republished with permission.

Case Conclusion The patient had a history of long-standing ET supported by a positive family history (present in 50% of patients) and response to alcohol In addition to the bilateral action tremor typical of ET, the examination demonstrates subtle features of asymmetric rest tremor, suggestive of early PD The clinical diagnosis is ET but you are concerned that she may have early PD in addition Two possible approaches −Clinical follow-up to see if she develops clearer features of parkinsonism −Obtain a dopamine transporter SPECT scan Patient elects to have the SPECT scan −SPECT demonstrates normal dopamine uptake −ET is confirmed

SPECT Images: Normal vs PD NormalEarly PD

Summary PD and ET are clinical diagnoses, but symptoms can sometimes overlap, causing misdiagnosis Timely and accurate diagnosis of PD and ET will advance appropriate treatment and improve the patient’s quality of life Patients with atypical symptoms may benefit from dopamine transporter SPECT to differentiate between a parkinsonian syndrome and ET

Thank you for participating in this activity. To proceed to the online CME test, click on the Earn CME Credit link on this page.